Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study

Raymond S. Douglas, George J. Kahaly, Shoaib Ugradar, Heike Elflein, Katharina A. Ponto, Brian T. Fowler, Roger Dailey, Gerald J. Harris, Jade Schiffman, Rosa Tang, Sara Wester, Amy Patel Jain, Claudio Marcocci, Michele Marinò, Alessandro Antonelli, Anja Eckstein, Dagmar Führer-Sakel, Mario Salvi, Saba Sile, Megan Francis-SedlakRobert J. Holt, Terry J. Smith

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study'. Together they form a unique fingerprint.

Medicine & Life Sciences